Related Experiment Video
Updated: Feb 11, 2026
Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
Published on: October 26, 2016
Drug-Eluting Stents Versus Bare-Metal Stents in Patients With End-Stage Renal Disease
Yushu Wang1, Sui Zhu2, Peijuan Gao3
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Background:
The clinical outcomes of drug-eluting stents versus bare-metal stents in end-stage renal disease patients remains controversial.
Methods:
A comprehensive literature search of Pubmed, Embase and Cochrane Library from January 2000 until November 2016 was conducted to identify relevant articles. We pooled the odds ratios (OR) from individual studies and conducted heterogeneity, quality assessment and publication bias analyses.
Results:
A total of 18 studies with 44,194 patients were identified. Compared with bare-metal stent-treated patients, drug-eluting stent-treated patients had significantly lower short-term and long-term all-cause mortality (OR = 0.56; 95% CI: 0.48-0.65; P < 0.00001; OR = 0.78; 95% CI: 0.66-0.92; P = 0.004, respectively), myocardial infarction (OR = 0.69; 95% CI: 0.53-0.88; P = 0.003) and major adverse cardiac events (OR = 0.72; 95% CI: 0.58-0.90; P = 0.004), with no detectable difference regarding stent thrombosis (OR = 0.80; 95% CI: 0.43-1.49; P = 0.47), cardiac mortality (OR = 0.95; 95% CI: 0.89-1.02; P = 0.14) and repeat revascularization (OR = 0.81; 95% CI: 0.62-1.06; P = 0.13).
Conclusions:
In patients with end-stage renal disease, the use of drug-eluting stents could significantly reduce the rates of mortality, myocardial infarction and major adverse cardiac events without increased risk of stent thrombosis. It poses imperative demands for future prospective randomized studies to define the optimal stent choice in this high-risk population.
Related Concept Videos
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
01:23Drug Elimination: Non-Renal Routes
01:15Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
01:06Renal Drug Clearance: Overview
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...